Mancuso M, Antonetti P, Serrao E, Colonna M, Mangialardi N
Unità Operativa di Radiologia Interventistica e Vascolare, Ospedale Sandro Pertini, Roma.
Radiol Med. 1998 Oct;96(4):384-8.
We investigated the feasibility of the intravascular treatment of iliac aneurysms in patients at high perioperative risk.
January, 1996, to December, 1997, seven iliac aneurysms in 5 patients were treated using endovascular procedures. The patients were 4 men and 1 woman whose mean age was 70 years (range: 61-74 years). Four of 7 aneurysms were in the common iliac artery (2 true aneurysms and 2 anastomotic aneurysms after aortoiliac bypass) and 3 were true internal iliac artery aneurysms. Preoperative CT and arteriography were performed in all cases to define the vascular morphology of the aneurysm, including its exact diameter and length. All procedures were performed in the operating room by a team of vascular radiologists and vascular surgeons, using a portable digital RX system (Philips BV29). The femoral approach was always used, which was percutaneous under local anesthesia in 4 cases and surgical under epidural anesthesia in the other 3 cases, according to the patient's general condition and to common femoral artery morphology. Six endovascular Passager grafts were positioned in the common iliac artery using over-the-wire techniques; platinum coil embolization of the aneurysmatic internal iliac artery had been performed in 2 cases. Coil embolization of the hypogastric artery aneurysm was the only treatment in 1 case. Bilateral aneurysms were treated separately, at intervals of no less than 3 months.
Immediate aneurysm exclusion was obtained in all cases, as confirmed at 2-20 months' follow-up in 6 cases. A displaced prosthesis needed reoperation in 1 case. No complications were observed during or early after the procedures, which were always well tolerated by the patients.
The endovascular treatment of iliac aneurysms is a relatively recent procedure and thus only short- and mid-run results are currently available, which appear satisfactory in 85% of the world's literature cases. Prosthesis displacement and intimal hyperplasia are reported as the main causes of failure. Lacking long-term results, we reserve this method to selected cases. Shorter hospitalization is another advantage.
This little invasive procedure appears suitable for high-risk patients and in the aneurysmatic complications metachronous to surgical bypass.
我们研究了对围手术期高风险患者进行髂动脉瘤血管内治疗的可行性。
1996年1月至1997年12月,对5例患者的7个髂动脉瘤采用血管内介入治疗。患者4例男性,1例女性,平均年龄70岁(范围:61 - 74岁)。7个动脉瘤中,4个位于髂总动脉(2个真性动脉瘤和2个腹主动脉 - 髂动脉旁路术后吻合口动脉瘤),3个为髂内动脉真性动脉瘤。所有病例术前行CT和血管造影以明确动脉瘤的血管形态,包括其确切直径和长度。所有手术均由血管放射科医生和血管外科医生团队在手术室进行,使用便携式数字RX系统(飞利浦BV29)。均采用股动脉入路,根据患者一般情况和股总动脉形态,4例在局部麻醉下经皮穿刺,另3例在硬膜外麻醉下手术切开。6个血管内Passager移植物采用导丝技术置于髂总动脉;2例对动脉瘤性髂内动脉进行了铂圈栓塞。1例患者仅对髂内动脉瘤进行了弹簧圈栓塞治疗。双侧动脉瘤分别治疗,间隔不少于3个月。
所有病例均实现了即刻动脉瘤隔绝,6例在2 - 20个月的随访中得到证实。1例出现移位假体需要再次手术。术中及术后早期未观察到并发症,患者耐受性良好。
髂动脉瘤的血管内治疗是一项相对较新的技术,目前仅有短期和中期结果,在世界文献报道的病例中85%效果似乎令人满意。假体移位和内膜增生被报道为失败的主要原因。由于缺乏长期结果,我们仅将该方法用于特定病例。住院时间较短是另一优点。
这种微创方法似乎适用于高风险患者以及与外科旁路手术相关的动脉瘤并发症。